Deryck Janse van Rensburg from Anchor Securities chose JP Morgan Chase & Co as his stock pick of the day and Gerbrand Smit from NeFG Fund Management chose Mediclinic.

Janse van Rensburg said: “I'm going abroad and choosing JP Morgan. Obviously we are on the back of some results and earnings season overseas and I think that the whole

banking sector overseas is actually reported stellar results and very strong results. On the back of good macroeconomic conditions and where the US market and economy is at the moment, I still think there's some room for growth. Yes the market is a little bit lofty in the short term since December lows. I would probably adopt in a sort of investment tactic to buy on weakness. I think the price to book ratio if you just look at the median on there to sitting at the moment at about 1.8 and that could expand to put towards about 2.3. I still think there is an upside on it - a patient investor should be well rewarded.”

Smit said: "I'm going for something that's been out of flavor for some time now and that is Mediclinic. About two years back everybody wanted to own the asset at around R220 a share, nothing could go wrong, they did a few purchases offshore in the Middle-East. Lots of things then went wrong in the Middle-East, regulatory issues where they had to do co-payments etc. Then, the regulatory issues in Switzerland so everything that probably could have gone wrong has gone wrong with Mediclinic in the earnings over the last two years. Everybody was running away from the share. It's now at around R64 a share"